ES2156860T3 - Tirosina quinasa. - Google Patents

Tirosina quinasa.

Info

Publication number
ES2156860T3
ES2156860T3 ES92915250T ES92915250T ES2156860T3 ES 2156860 T3 ES2156860 T3 ES 2156860T3 ES 92915250 T ES92915250 T ES 92915250T ES 92915250 T ES92915250 T ES 92915250T ES 2156860 T3 ES2156860 T3 ES 2156860T3
Authority
ES
Spain
Prior art keywords
tyrosine kinase
wild
strand break
dna double
break repair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92915250T
Other languages
English (en)
Inventor
Merl F Hoekstra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Application granted granted Critical
Publication of ES2156860T3 publication Critical patent/ES2156860T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

QUINASA DE TIROSINA MUTANTE Y GENES DE TIPO LIBRE UTILES EN EL FILTRAR DE COMPOSICIONES QUE PUEDEN AFECTAR A LA ACTIVIDAD DE REPARACION DE ROTURA DE CORDON DOBLE DE ADN
ES92915250T 1991-07-03 1992-07-01 Tirosina quinasa. Expired - Lifetime ES2156860T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72878391A 1991-07-03 1991-07-03

Publications (1)

Publication Number Publication Date
ES2156860T3 true ES2156860T3 (es) 2001-08-01

Family

ID=24928264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92915250T Expired - Lifetime ES2156860T3 (es) 1991-07-03 1992-07-01 Tirosina quinasa.

Country Status (8)

Country Link
US (1) US5705377A (es)
EP (1) EP0594710B1 (es)
JP (1) JPH06510664A (es)
AT (1) ATE199395T1 (es)
CA (1) CA2112748A1 (es)
DE (1) DE69231710T2 (es)
ES (1) ES2156860T3 (es)
WO (1) WO1993001205A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060296A (en) * 1991-07-03 2000-05-09 The Salk Institute For Biological Studies Protein kinases
EP0632832A1 (en) * 1993-01-21 1995-01-11 The Salk Institute For Biological Studies Protein kinases
US7590493B2 (en) 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
EP1392871A4 (en) 2001-05-22 2006-04-19 Gene Logic Inc MODELING MOLECULAR TOXICITY
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling

Also Published As

Publication number Publication date
DE69231710T2 (de) 2001-09-20
CA2112748A1 (en) 1993-01-21
EP0594710B1 (en) 2001-02-28
EP0594710A1 (en) 1994-05-04
DE69231710D1 (de) 2001-04-05
EP0594710A4 (en) 1994-11-02
JPH06510664A (ja) 1994-12-01
WO1993001205A1 (en) 1993-01-21
US5705377A (en) 1998-01-06
ATE199395T1 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
ATE181559T1 (de) Proteinkinase
DE69840025D1 (de) Assoziierter antworten
DE69942627D1 (de) Verstärkungs- und Pegelregelungen von optischen Verstärkern in Kaskade
ATE378348T1 (de) Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
LU91758I9 (es)
FI973467A0 (fi) DNA-molekyylejä, valmistus ja käyttö geeniterapiassa
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
CY1108348T1 (el) Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
BR9607347A (pt) Esteres e amidas de 1,4-piperidina dissubstítuída possuindo atividade antagonística 5-ht
DE69917370D1 (de) Verwendung von disubstituierten Ethylen-Maleimid-Copolymeren in Kautschuk-Zusammensetzungen
CY2476B1 (en) Benzonaphthyridines as bronchial therapeutics.
DE69226763D1 (de) Härten von fluoroelastomeren
DK0760010T3 (da) Fremgangsmåder til screening for Crohn's sygdom under anvendelse af TNF-mikrosatellit-alleler
ATE227561T1 (de) Verwendung von alpha-alkylglucosiden und deren estern als antimikrobielle emulgatoren
DE69231710D1 (de) Tyrosinkinase
DE69727625D1 (de) Aufzeichnung von On-Line-Dokumenten
NZ326596A (en) Isolated vertebrate signalin gene peptide and use in intracellular signal transduction pathways mediated by TGF beta
DK0981644T3 (da) APC mutation, der står i forbindelse med familierelateret colorectal cancer hos Ashkenazi -jøder
WO1994017189A3 (en) Protein kinases
AU2932100A (en) Neurodegenerative disorder related gene
DE69130845D1 (de) HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung
NO990849D0 (no) Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner
AU6906396A (en) Methods and compositions including dna damaging agents and tyrosine kinase inhibitors or activators
BR0113266A (pt) Métodos para modular proteìnas quinase de linhagem múltipla e compostos protetores que modulam proteìnas quinase de linhagem múltipla
GB0102712D0 (en) Cytokine Producion and Tyrosine Kinase Inhibitors

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 594710

Country of ref document: ES